English
French
Indonesian
Korean
Malay805-P — 2012: Improved Glycemic Control and Variability During Insulin Intensification Improve Patient-Centered Outcomes in Type 1 Diabetes
Psychosocial – Behavioral Medicine Presented on Saturday, June 9, 2012 11:30 AM Author(s): MARCIAA. TESTA, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, DONALD C. SIMONSON, Boston, MA, Bridgewater, NJ, Wellesley, MA. It is generally accepted that higher glucose levels.
850-P — 2012: Assessing the Comparative Effectiveness (CE) of Basal-Bolus vs. Premix Insulin Using Continuous Glucose Monitoring (CGM) Summary Measures
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 10, 2012 12:00 PM Author(s): DONALD C. SIMONSON, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, MARCIAA. TESTA, Boston, MA, Bridgewater, NJ, Wellesley, MA. CGM is an effective.
Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes
Session: New Findings from Controlled Behavioral Interventions Abstract Number: 1-OR Title: Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes Presentation Start: 6/21/2013 4:15:00 PM Presentation End: 6/21/2013 4:30:00 PM Authors: DONALD C. SIMONSON, ANN GOEBEL-FABBRI,.
681-P — 2013: Socioeconomic and Demographic Predictors of Internet and Social Media Use in Persons with Diabetes
Diabetes Education Presented on Monday, June 24, 2013 12:00 PM Author(s): MARCIAA. TESTA, DONALD C. SIMONSON, Boston, MA. Internet and social media tools to access and disseminate health information have increased dramatically; however, there are limited data on their.
1165-P — 2014 ePoster: Development of a Personalized, Patient-Centered Glycemic Control Benchmarking Tool for T2DM
MARCIA A. TESTA, DONALD C. SIMONSON, Boston, MA Presented on Sunday, June 15, 2014 12:00 PM Author(s): MARCIAA. TESTA, DONALD C. SIMONSON, Boston, MA Glycemic control treatment targets for T2DM are intended to trigger clinical action in the management.
839-P — 2014 CGM and SMBG Analytics Predict Hypoglycemic Risk and Symptoms during Intensive Insulin Titration
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 15, 2014 12:00 PM Author(s): MARCIAA. TESTA, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, DONALD C. SIMONSON, Boston, MA, Bridgewater, NJ, Wellesley,MA The relationship between hypoglycemia (HYPO), glycemic excursions and symptoms during intensive insulin.
Load more